SCHEMBL30567337

SCHEMBL30567337

CN(C)C(=O)c1ccc(S(N)(=O)=O)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CDK1 P06493 1/20 0.39
CDK2 P24941 1/20 0.39
ESR1 P03372 2/20 0.39
ESR2 Q92731 2/20 0.39
PKM P14618 1/20 0.39
CA2 P00918 3/20 0.38
NEU3 Q9UQ49 1/20 0.38
PDK2 Q15119 4/20 0.37
PDK4 Q16654 2/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
HSP90AA1 P07900 2/20 0.36
HSP90AB1 P08238 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK3 Q15120 1/20 0.36
CA12 O43570 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20680906 1.00 ERN1 (0.40) ERN1ALDH1A1HPGDSMN1; SMN2CDK1
SCHEMBL2776082 0.87 ERN1 (0.43) ERN1ALDH1A1HPGDSMN1; SMN2CDK1
SCHEMBL20692171 0.84 ERN1 (0.40) ERN1ALDH1A1HPGDSMN1; SMN2ESR1
SCHEMBL25067050 0.82 PDIA6 (0.44) ERN1ALDH1A1HPGDSMN1; SMN2CDK1
SCHEMBL21962335 0.82 CNR2 (0.50) ALDH1A1HPGDSMN1; SMN2PDK2
SCHEMBL6514562 0.81 CA2 (0.46) ALDH1A1PKMCA2NEU3PTGS1
SCHEMBL2777527 0.80 NEU3 (0.57) SMN1; SMN2PKMCA2NEU3PTGS2
SCHEMBL29787231 0.80 NEU3 (0.57) SMN1; SMN2PKMCA2NEU3PTGS2
SCHEMBL355413 0.78 ESR1 (0.60) ERN1ALDH1A1HPGDSMN1; SMN2ESR1
SCHEMBL11560883 0.77 CA1 (0.55) SMN1; SMN2CA2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117209447-A Compounds and compositions for treating disorders associated with NLRP activity 诺华股份有限公司 2023-12-12 CN disclosed
CN-117143042-A Compounds and compositions for treating disorders associated with NLRP activity 诺华股份有限公司 2023-12-01 CN disclosed
CN-111094243-B Compounds and compositions for treating disorders associated with NLRP activity 诺华股份有限公司 2023-09-05 CN disclosed